Top Markets
Coin of the day
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
Classement en actions #17262
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
Prix de l'action
$0.873
Capitalisation boursière
$257.19M
Changement (1 jour)
-0.78%
Changement (1 an)
-15.24%
Pays
US
Échange Invivyd, Inc. (IVVD)

Catégorie

Historique du prix de l'action pour Invivyd, Inc. (IVVD)
Prix de clôture le plus élevé : $0.88 le 2026-09-01

Prix de clôture le plus bas : $27.68 le 2021-08-01
Historique du prix de l'action de Invivyd, Inc. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -37.39%
2025 355.72%
2024 -79.42%
2023 46.08%
2022 -91.63%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$553.36 37.99%
US
$1.06K 49.97%
NL
$155.59 543.18%
US
$122.21 -10.03%
AU
$762.65 8.90%
CH